Literature DB >> 21073283

Persistent cognitive impairment after cerebral malaria: models, mechanisms and adjunctive therapies.

Guy A Zimmerman, Hugo Castro-Faria-Neto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21073283     DOI： 10.1586/eri.10.117

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN： 1478-7210            Impact factor:   5.091


× No keyword cloud information.
  9 in total

Review 1.  Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.

Authors:  Robert A Floyd; Hugo C Castro Faria Neto; Guy A Zimmerman; Kenneth Hensley; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2013-02-16       Impact factor: 7.376

2.  Malaria parasite heme biosynthesis promotes and griseofulvin protects against cerebral malaria in mice.

Authors:  Manjunatha Chandana; Aditya Anand; Sourav Ghosh; Rahul Das; Subhashree Beura; Sarita Jena; Amol Ratnakar Suryawanshi; Govindarajan Padmanaban; Viswanathan Arun Nagaraj
Journal:  Nat Commun       Date:  2022-07-12       Impact factor: 17.694

Review 3.  Adjunctive therapy for severe malaria: a review and critical appraisal.

Authors:  Rosauro Varo; Valerie M Crowley; Antonio Sitoe; Lola Madrid; Lena Serghides; Kevin C Kain; Quique Bassat
Journal:  Malar J       Date:  2018-01-24       Impact factor: 2.979

4.  A quantitative brain map of experimental cerebral malaria pathology.

Authors:  Patrick Strangward; Michael J Haley; Tovah N Shaw; Jean-Marc Schwartz; Rachel Greig; Aleksandr Mironov; J Brian de Souza; Sheena M Cruickshank; Alister G Craig; Danny A Milner; Stuart M Allan; Kevin N Couper
Journal:  PLoS Pathog       Date:  2017-03-08       Impact factor: 6.823

Review 5.  Slums are not places for children to live: vulnerabilities, health outcomes, and possible interventions.

Authors:  Kacey C Ernst; Beth S Phillips; Burris Duke Duncan
Journal:  Adv Pediatr       Date:  2013-07-17

6.  Key factors predicting suspected severe malaria case management and health outcomes: an operational study in the Democratic Republic of the Congo.

Authors:  Jean Okitawutshu; Aita Signorell; Jean-Claude Kalenga; Eric Mukomena; Giulia Delvento; Christian Burri; Fatou Mwaluke; Valentina Buj; Moulaye Sangare; Sylvie Luketa; Nina Brunner; Tristan Lee; Manuel Hetzel; Christian Lengeler; Antoinette Tshefu
Journal:  Malar J       Date:  2022-09-27       Impact factor: 3.469

7.  Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.

Authors:  Patricia A Reis; Vanessa Estato; Tathiany I da Silva; Joana C d'Avila; Luciana D Siqueira; Edson F Assis; Patricia T Bozza; Fernando A Bozza; Eduardo V Tibiriça; Guy A Zimmerman; Hugo C Castro-Faria-Neto
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

8.  Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.

Authors:  Nana O Wilson; Wesley Solomon; Leonard Anderson; John Patrickson; Sidney Pitts; Vincent Bond; Mingli Liu; Jonathan K Stiles
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

9.  Early prediction of cerebral malaria by (1)H NMR based metabolomics.

Authors:  Soumita Ghosh; Arjun Sengupta; Shobhona Sharma; Haripalsingh M Sonawat
Journal:  Malar J       Date:  2016-04-12       Impact factor: 2.979
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.